Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by Gusstoon Jan 03, 2018 3:23pm

98 Views

Post# 27273319

Level 2 still looking good, better than this board...

Level ll Quote
Bid			Ask
Price	Total Size	# of Orders	Price	Total Size	# of Orders

$0.25	554000	56	$0.255	19500	3
$0.245	438000	9	$0.26	681000	20
$0.24	1007500	39	$0.265	436000	14
$0.235	282500	14	$0.27	267000	10
$0.23	628500	30	$0.275	84500	7
$0.225	194000	9	$0.28	218500	14
$0.22	705000	38	$0.285	115000	6
$0.215	235000	4	$0.29	137000	8
$0.21	368000	16	$0.295	94500	5
$0.205	48500	5	$0.30	670000	38